Litigation Details for Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-07-23 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,065,952 | ||
| Link to Docket | External link to docket | ||
Details for Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-07-23 | 1 | Complaint | civil action for patent infringement of U.S. Patent Nos. 10,065,952 (“the ’952 patent”), 10,844,058 (“…Paragraph IV certification with respect to U.S. Patent Nos. 10,065,952; 10,844,058; 10,851,103; 10,851,104; 10,857,137…Paragraph IV certification with respect to U.S. Patent Nos. 10,065,952; 10,844,058; 10,851,103; 10,851,104; 10,857,137…(“the ’058 patent”), 10,851,103 (“the ’103 patent”), 10,851,104 (“the ’104 patent”), 10,857,137 (“the…the ’137 patent”), 10,857,148 (“the ’148 patent”), 10,874,648 (“the ’648 patent”), 10,906,902 (“the ’902 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
